The global Monoclonal Antibody Biologics and Biosimilars market was valued at 236060 million in 2024 and is projected to reach US$ 544370 million by 2031, at a CAGR of 13.0% during the forecast period.
Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.
The monoclonal antibody medicine market is driven by the growing demand for targeted and personalized therapies and the significant advancements in biotechnology and antibody engineering. Monoclonal antibodies (mAbs) offer precise targeting of specific antigens, making them highly effective in treating various diseases, including cancer, autoimmune disorders, and infectious diseases. Their ability to modulate the immune response and their potential for fewer side effects compared to traditional treatments have fueled their popularity among healthcare providers and patients. Moreover, the development of novel mAbs and the expansion of approved indications for existing therapies further contribute to market growth. However, the market also faces challenges, including the high cost of mAb therapies, which can limit patient access and reimbursement. Additionally, the complex manufacturing process and regulatory requirements for mAb medicines can be obstacles for new market entrants. To succeed in this competitive market, manufacturers must focus on improving affordability, exploring biosimilar opportunities, and investing in research and development to develop innovative and differentiated monoclonal antibody medicines that address unmet medical needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Monoclonal Antibody Biologics and Biosimilars companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibody Biologics and Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibody Biologics and Biosimilars. This report contains market size and forecasts of Monoclonal Antibody Biologics and Biosimilars in global, including the following market information:
Global Monoclonal Antibody Biologics and Biosimilars market revenue, 2020-2025, 2026-2031, ($ millions)
Global top five Monoclonal Antibody Biologics and Biosimilars companies in 2024 (%)
Total Market by Segment:
Global Monoclonal Antibody Biologics and Biosimilars market, by Type, 2020-2025, 2026-2031 ($ millions)
Global Monoclonal Antibody Biologics and Biosimilars market segment percentages, by Type, 2024 (%)
Biologics
Biosimilars
Global Monoclonal Antibody Biologics and Biosimilars market, by Application, 2020-2025, 2026-2031 ($ millions)
Global Monoclonal Antibody Biologics and Biosimilars market segment percentages, by Application, 2024 (%)
Cancer
Autoimmune Disease
Other
Global Monoclonal Antibody Biologics and Biosimilars market, by region and country, 2020-2025, 2026-2031 ($ millions)
Global Monoclonal Antibody Biologics and Biosimilars market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Monoclonal Antibody Biologics and Biosimilars revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Monoclonal Antibody Biologics and Biosimilars revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Eli Lilly
Novartis
Merck
Biogen
Celltrion
Sobi
3SBIO
Innovent Biologics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Monoclonal Antibody Biologics and Biosimilars, market overview.
Chapter 2: Global Monoclonal Antibody Biologics and Biosimilars market size in revenue.
Chapter 3: Detailed analysis of Monoclonal Antibody Biologics and Biosimilars company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Monoclonal Antibody Biologics and Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Monoclonal Antibody Biologics and Biosimilars Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Monoclonal Antibody Biologics and Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Monoclonal Antibody Biologics and Biosimilars Overall Market Size
2.1 Global Monoclonal Antibody Biologics and Biosimilars Market Size: 2024 VS 2031
2.2 Global Monoclonal Antibody Biologics and Biosimilars Market Size, Prospects & Forecasts: 2020-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Monoclonal Antibody Biologics and Biosimilars Players in Global Market
3.2 Top Global Monoclonal Antibody Biologics and Biosimilars Companies Ranked by Revenue
3.3 Global Monoclonal Antibody Biologics and Biosimilars Revenue by Companies
3.4 Top 3 and Top 5 Monoclonal Antibody Biologics and Biosimilars Companies in Global Market, by Revenue in 2024
3.5 Global Companies Monoclonal Antibody Biologics and Biosimilars Product Type
3.6 Tier 1, Tier 2, and Tier 3 Monoclonal Antibody Biologics and Biosimilars Players in Global Market
3.6.1 List of Global Tier 1 Monoclonal Antibody Biologics and Biosimilars Companies
3.6.2 List of Global Tier 2 and Tier 3 Monoclonal Antibody Biologics and Biosimilars Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Monoclonal Antibody Biologics and Biosimilars Market Size Markets, 2024 & 2031
4.1.2 Biologics
4.1.3 Biosimilars
4.2 Segmentation by Type - Global Monoclonal Antibody Biologics and Biosimilars Revenue & Forecasts
4.2.1 Segmentation by Type - Global Monoclonal Antibody Biologics and Biosimilars Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Monoclonal Antibody Biologics and Biosimilars Revenue, 2026-2031
4.2.3 Segmentation by Type - Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Monoclonal Antibody Biologics and Biosimilars Market Size, 2024 & 2031
5.1.2 Cancer
5.1.3 Autoimmune Disease
5.1.4 Other
5.2 Segmentation by Application - Global Monoclonal Antibody Biologics and Biosimilars Revenue & Forecasts
5.2.1 Segmentation by Application - Global Monoclonal Antibody Biologics and Biosimilars Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Monoclonal Antibody Biologics and Biosimilars Revenue, 2026-2031
5.2.3 Segmentation by Application - Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2020-2031
6 Sights by Region
6.1 By Region - Global Monoclonal Antibody Biologics and Biosimilars Market Size, 2024 & 2031
6.2 By Region - Global Monoclonal Antibody Biologics and Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Monoclonal Antibody Biologics and Biosimilars Revenue, 2020-2025
6.2.2 By Region - Global Monoclonal Antibody Biologics and Biosimilars Revenue, 2026-2031
6.2.3 By Region - Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2020-2031
6.3 North America
6.3.1 By Country - North America Monoclonal Antibody Biologics and Biosimilars Revenue, 2020-2031
6.3.2 United States Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.3.3 Canada Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.3.4 Mexico Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.4 Europe
6.4.1 By Country - Europe Monoclonal Antibody Biologics and Biosimilars Revenue, 2020-2031
6.4.2 Germany Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.4.3 France Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.4.4 U.K. Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.4.5 Italy Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.4.6 Russia Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.4.7 Nordic Countries Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.4.8 Benelux Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.5 Asia
6.5.1 By Region - Asia Monoclonal Antibody Biologics and Biosimilars Revenue, 2020-2031
6.5.2 China Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.5.3 Japan Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.5.4 South Korea Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.5.5 Southeast Asia Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.5.6 India Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.6 South America
6.6.1 By Country - South America Monoclonal Antibody Biologics and Biosimilars Revenue, 2020-2031
6.6.2 Brazil Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.6.3 Argentina Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Revenue, 2020-2031
6.7.2 Turkey Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.7.3 Israel Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.7.4 Saudi Arabia Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
6.7.5 UAE Monoclonal Antibody Biologics and Biosimilars Market Size, 2020-2031
7 Companies Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Monoclonal Antibody Biologics and Biosimilars Major Product Offerings
7.1.4 Roche Monoclonal Antibody Biologics and Biosimilars Revenue in Global Market (2020-2025)
7.1.5 Roche Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Monoclonal Antibody Biologics and Biosimilars Major Product Offerings
7.2.4 Amgen Monoclonal Antibody Biologics and Biosimilars Revenue in Global Market (2020-2025)
7.2.5 Amgen Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Corporate Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Monoclonal Antibody Biologics and Biosimilars Major Product Offerings
7.3.4 AbbVie Monoclonal Antibody Biologics and Biosimilars Revenue in Global Market (2020-2025)
7.3.5 AbbVie Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Monoclonal Antibody Biologics and Biosimilars Major Product Offerings
7.4.4 Sanofi Monoclonal Antibody Biologics and Biosimilars Revenue in Global Market (2020-2025)
7.4.5 Sanofi Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Major Product Offerings
7.5.4 Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Revenue in Global Market (2020-2025)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Monoclonal Antibody Biologics and Biosimilars Major Product Offerings
7.6.4 Pfizer Monoclonal Antibody Biologics and Biosimilars Revenue in Global Market (2020-2025)
7.6.5 Pfizer Key News & Latest Developments
7.7 Eli Lilly
7.7.1 Eli Lilly Corporate Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Monoclonal Antibody Biologics and Biosimilars Major Product Offerings
7.7.4 Eli Lilly Monoclonal Antibody Biologics and Biosimilars Revenue in Global Market (2020-2025)
7.7.5 Eli Lilly Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Monoclonal Antibody Biologics and Biosimilars Major Product Offerings
7.8.4 Novartis Monoclonal Antibody Biologics and Biosimilars Revenue in Global Market (2020-2025)
7.8.5 Novartis Key News & Latest Developments
7.9 Merck
7.9.1 Merck Corporate Summary
7.9.2 Merck Business Overview
7.9.3 Merck Monoclonal Antibody Biologics and Biosimilars Major Product Offerings
7.9.4 Merck Monoclonal Antibody Biologics and Biosimilars Revenue in Global Market (2020-2025)
7.9.5 Merck Key News & Latest Developments
7.10 Biogen
7.10.1 Biogen Corporate Summary
7.10.2 Biogen Business Overview
7.10.3 Biogen Monoclonal Antibody Biologics and Biosimilars Major Product Offerings
7.10.4 Biogen Monoclonal Antibody Biologics and Biosimilars Revenue in Global Market (2020-2025)
7.10.5 Biogen Key News & Latest Developments
7.11 Celltrion
7.11.1 Celltrion Corporate Summary
7.11.2 Celltrion Business Overview
7.11.3 Celltrion Monoclonal Antibody Biologics and Biosimilars Major Product Offerings
7.11.4 Celltrion Monoclonal Antibody Biologics and Biosimilars Revenue in Global Market (2020-2025)
7.11.5 Celltrion Key News & Latest Developments
7.12 Sobi
7.12.1 Sobi Corporate Summary
7.12.2 Sobi Business Overview
7.12.3 Sobi Monoclonal Antibody Biologics and Biosimilars Major Product Offerings
7.12.4 Sobi Monoclonal Antibody Biologics and Biosimilars Revenue in Global Market (2020-2025)
7.12.5 Sobi Key News & Latest Developments
7.13 3SBIO
7.13.1 3SBIO Corporate Summary
7.13.2 3SBIO Business Overview
7.13.3 3SBIO Monoclonal Antibody Biologics and Biosimilars Major Product Offerings
7.13.4 3SBIO Monoclonal Antibody Biologics and Biosimilars Revenue in Global Market (2020-2025)
7.13.5 3SBIO Key News & Latest Developments
7.14 Innovent Biologics
7.14.1 Innovent Biologics Corporate Summary
7.14.2 Innovent Biologics Business Overview
7.14.3 Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Major Product Offerings
7.14.4 Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Revenue in Global Market (2020-2025)
7.14.5 Innovent Biologics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Monoclonal Antibody Biologics and Biosimilars Market Opportunities & Trends in Global Market
Table 2. Monoclonal Antibody Biologics and Biosimilars Market Drivers in Global Market
Table 3. Monoclonal Antibody Biologics and Biosimilars Market Restraints in Global Market
Table 4. Key Players of Monoclonal Antibody Biologics and Biosimilars in Global Market
Table 5. Top Monoclonal Antibody Biologics and Biosimilars Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Monoclonal Antibody Biologics and Biosimilars Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Monoclonal Antibody Biologics and Biosimilars Revenue Share by Companies, 2020-2025
Table 8. Global Companies Monoclonal Antibody Biologics and Biosimilars Product Type
Table 9. List of Global Tier 1 Monoclonal Antibody Biologics and Biosimilars Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Monoclonal Antibody Biologics and Biosimilars Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type – Global Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2024 & 2031
Table 12. Segmentation by Type - Global Monoclonal Antibody Biologics and Biosimilars Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Monoclonal Antibody Biologics and Biosimilars Revenue (US$, Mn), 2026-2031
Table 14. Segmentation by Application– Global Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2024 & 2031
Table 15. Segmentation by Application - Global Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2026-2031
Table 17. By Region– Global Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2024 & 2031
Table 18. By Region - Global Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2026-2031
Table 20. By Country - North America Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2026-2031
Table 22. By Country - Europe Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Asia Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2026-2031
Table 26. By Country - South America Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2026-2031
Table 28. By Country - Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2026-2031
Table 30. Roche Corporate Summary
Table 31. Roche Monoclonal Antibody Biologics and Biosimilars Product Offerings
Table 32. Roche Monoclonal Antibody Biologics and Biosimilars Revenue (US$, Mn) & (2020-2025)
Table 33. Roche Key News & Latest Developments
Table 34. Amgen Corporate Summary
Table 35. Amgen Monoclonal Antibody Biologics and Biosimilars Product Offerings
Table 36. Amgen Monoclonal Antibody Biologics and Biosimilars Revenue (US$, Mn) & (2020-2025)
Table 37. Amgen Key News & Latest Developments
Table 38. AbbVie Corporate Summary
Table 39. AbbVie Monoclonal Antibody Biologics and Biosimilars Product Offerings
Table 40. AbbVie Monoclonal Antibody Biologics and Biosimilars Revenue (US$, Mn) & (2020-2025)
Table 41. AbbVie Key News & Latest Developments
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Monoclonal Antibody Biologics and Biosimilars Product Offerings
Table 44. Sanofi Monoclonal Antibody Biologics and Biosimilars Revenue (US$, Mn) & (2020-2025)
Table 45. Sanofi Key News & Latest Developments
Table 46. Johnson & Johnson Corporate Summary
Table 47. Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Product Offerings
Table 48. Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Revenue (US$, Mn) & (2020-2025)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Pfizer Corporate Summary
Table 51. Pfizer Monoclonal Antibody Biologics and Biosimilars Product Offerings
Table 52. Pfizer Monoclonal Antibody Biologics and Biosimilars Revenue (US$, Mn) & (2020-2025)
Table 53. Pfizer Key News & Latest Developments
Table 54. Eli Lilly Corporate Summary
Table 55. Eli Lilly Monoclonal Antibody Biologics and Biosimilars Product Offerings
Table 56. Eli Lilly Monoclonal Antibody Biologics and Biosimilars Revenue (US$, Mn) & (2020-2025)
Table 57. Eli Lilly Key News & Latest Developments
Table 58. Novartis Corporate Summary
Table 59. Novartis Monoclonal Antibody Biologics and Biosimilars Product Offerings
Table 60. Novartis Monoclonal Antibody Biologics and Biosimilars Revenue (US$, Mn) & (2020-2025)
Table 61. Novartis Key News & Latest Developments
Table 62. Merck Corporate Summary
Table 63. Merck Monoclonal Antibody Biologics and Biosimilars Product Offerings
Table 64. Merck Monoclonal Antibody Biologics and Biosimilars Revenue (US$, Mn) & (2020-2025)
Table 65. Merck Key News & Latest Developments
Table 66. Biogen Corporate Summary
Table 67. Biogen Monoclonal Antibody Biologics and Biosimilars Product Offerings
Table 68. Biogen Monoclonal Antibody Biologics and Biosimilars Revenue (US$, Mn) & (2020-2025)
Table 69. Biogen Key News & Latest Developments
Table 70. Celltrion Corporate Summary
Table 71. Celltrion Monoclonal Antibody Biologics and Biosimilars Product Offerings
Table 72. Celltrion Monoclonal Antibody Biologics and Biosimilars Revenue (US$, Mn) & (2020-2025)
Table 73. Celltrion Key News & Latest Developments
Table 74. Sobi Corporate Summary
Table 75. Sobi Monoclonal Antibody Biologics and Biosimilars Product Offerings
Table 76. Sobi Monoclonal Antibody Biologics and Biosimilars Revenue (US$, Mn) & (2020-2025)
Table 77. Sobi Key News & Latest Developments
Table 78. 3SBIO Corporate Summary
Table 79. 3SBIO Monoclonal Antibody Biologics and Biosimilars Product Offerings
Table 80. 3SBIO Monoclonal Antibody Biologics and Biosimilars Revenue (US$, Mn) & (2020-2025)
Table 81. 3SBIO Key News & Latest Developments
Table 82. Innovent Biologics Corporate Summary
Table 83. Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Product Offerings
Table 84. Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Revenue (US$, Mn) & (2020-2025)
Table 85. Innovent Biologics Key News & Latest Developments
List of Figures
Figure 1. Monoclonal Antibody Biologics and Biosimilars Product Picture
Figure 2. Monoclonal Antibody Biologics and Biosimilars Segment by Type in 2024
Figure 3. Monoclonal Antibody Biologics and Biosimilars Segment by Application in 2024
Figure 4. Global Monoclonal Antibody Biologics and Biosimilars Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Monoclonal Antibody Biologics and Biosimilars Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Monoclonal Antibody Biologics and Biosimilars Revenue: 2020-2031 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Monoclonal Antibody Biologics and Biosimilars Revenue in 2024
Figure 9. Segmentation by Type – Global Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2024 & 2031
Figure 10. Segmentation by Type - Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2020-2031
Figure 11. Segmentation by Application – Global Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2024 & 2031
Figure 12. Segmentation by Application - Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2020-2031
Figure 13. By Region - Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2020-2031
Figure 14. By Country - North America Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2020-2031
Figure 15. United States Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 16. Canada Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 17. Mexico Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 18. By Country - Europe Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2020-2031
Figure 19. Germany Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 20. France Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 21. U.K. Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 22. Italy Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 23. Russia Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 24. Nordic Countries Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 25. Benelux Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 26. By Region - Asia Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2020-2031
Figure 27. China Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 28. Japan Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 29. South Korea Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 30. Southeast Asia Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 31. India Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 32. By Country - South America Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2020-2031
Figure 33. Brazil Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 34. Argentina Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 35. By Country - Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2020-2031
Figure 36. Turkey Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 37. Israel Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 38. Saudi Arabia Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 39. UAE Monoclonal Antibody Biologics and Biosimilars Revenue, (US$, Mn), 2020-2031
Figure 40. Roche Monoclonal Antibody Biologics and Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Amgen Monoclonal Antibody Biologics and Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. AbbVie Monoclonal Antibody Biologics and Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Sanofi Monoclonal Antibody Biologics and Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Pfizer Monoclonal Antibody Biologics and Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Eli Lilly Monoclonal Antibody Biologics and Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Novartis Monoclonal Antibody Biologics and Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Merck Monoclonal Antibody Biologics and Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Biogen Monoclonal Antibody Biologics and Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Celltrion Monoclonal Antibody Biologics and Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Sobi Monoclonal Antibody Biologics and Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. 3SBIO Monoclonal Antibody Biologics and Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
